Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2012-01-30T13:53:36Z
dc.date.available 2012-01-30T03:00:00Z
dc.date.issued 2011 es
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/8389
dc.description.abstract Cylin dependent kinases (CDKs) have emerged as novel mechanistic target due to their direct involvement in underlying genetic changes during the cancerous state. In order to identify the essential physiochemical parameters for CDK2 inhibitory activity in some 3-aminopyrazole derivatives, Quantitative Structure-Activity Relationship (QSAR) studies have been carried out on a series of total 35 compounds (taking 24 and 11 molecules in trainings set and test set respectively) using the multiple linear regression MLR) method. Among the generated models, the best QSAR model with good correlation coefficient (r2 = 0.643) along high statistical significance (> 99.9 %) well explained variance in activity for both training and test set molecules (Pred. r2 = 0.632). The two dimensional QSAR studies revealed that the activity is positively controlled by the indicator parameter (I), electronic parameter (field effect, F) and hydrophobic fragmentation constant (Fr) of substituents. Apart from that one of the interesting finding is that this model well discriminates between the Molar refractivity (MR) and hydrophobic fragmentation constant (Fr) in prediction of inhibitory activities based on the regression coefficient and associated error. Further the calculation of important descriptors like log P, hydrogen bond donor and acceptors etc. indicates the potential of these molecules in clinical trial as an anticancer drug. es
dc.format.extent 1877-1882 es
dc.language en es
dc.subject QSAR; Hansch analysis; 3-aminopyrazole derivatives; Lipinski's rule es
dc.subject Quinasas Ciclina-Dependientes es
dc.subject Pirazoles es
dc.title QSAR studies on aminopyrazoles for the prediction of inhibition of CDK2/Cyclin A as antitumor agents es
dc.type Articulo es
sedici.identifier.uri http://www.latamjpharm.org/resumenes/30/10/LAJOP_30_10_1_1.pdf es
sedici.creator.person Jain, Sonika es
sedici.creator.person Kishore, Dharma es
sedici.creator.person Dwivedi, Jaya es
sedici.subject.materias Farmacia es
sedici.description.fulltext false es
mods.originInfo.place Colegio de Farmacéuticos de la Provincia de Buenos Aires es
sedici.subtype Articulo es
sedici.description.peerReview peer-review es
sedici2003.identifier ARG-FARM-ART-0000001877 es
sedici.relation.journalTitle Latin American Journal of Pharmacy es
sedici.relation.journalVolumeAndIssue vol. 30, no. 10 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)